Wambach G, Helber A
Clin Exp Hypertens (1978). 1981;3(4):663-73. doi: 10.3109/10641968109033692.
In search for a diagnostic marker for essential hypertension, we investigated the activity of the ouabain sensitive Na-K-ATPase and the ouabain insensitive ATPase in erythrocyte ghosts of 57 patients with essential hypertension, 12 patients with renal hypertension, 6 patients with Cushing's syndrome and 4 patients with primary hyperaldosteronism. Na-K-ATPase-activity was increased in patients with essential hypertension and in patients with renal hypertension compared with controls with a considerable overlap. Na-K-ATPase-activity was increased in all patients with Cushing's syndrome but was not different from the control group in patients with Conn's syndrome. Ouabain-insensitive ATPase-activity was similar in all patients and in normotensive controls. The serum of patients with essential hypertension did not exhibit an ouabain-like ATPase-inhibiting activity when incubated with erythrocyte ghosts of normotensive controls. In our hands, determination of the Na-K-ATPase-activity in erythrocyte ghosts cannot be used as a diagnostic marker for essential hypertension.
为寻找原发性高血压的诊断标志物,我们研究了57例原发性高血压患者、12例肾性高血压患者、6例库欣综合征患者和4例原发性醛固酮增多症患者红细胞膜上哇巴因敏感的钠钾ATP酶及哇巴因不敏感的ATP酶的活性。与对照组相比,原发性高血压患者和肾性高血压患者的钠钾ATP酶活性增加,且有相当程度的重叠。所有库欣综合征患者的钠钾ATP酶活性均增加,但原发性醛固酮增多症患者与对照组无差异。所有患者及血压正常的对照组中,哇巴因不敏感的ATP酶活性相似。原发性高血压患者的血清与血压正常对照组的红细胞膜温育时,未表现出类似哇巴因的ATP酶抑制活性。在我们的研究中,测定红细胞膜上的钠钾ATP酶活性不能用作原发性高血压的诊断标志物。